Familial Hypercholesterolemia--Screening to Facilitate Early Prevention

Parhofer, Klaus G.
August 2014
Deutsches Aerzteblatt International;8/4/2014, Vol. 111 Issue 31/32, p521
Academic Journal
An introduction is presented in which the editor discusses a report in the journal concerning developments in the diagnosis and treatment of familial hypercholesterolemia.


Related Articles

  • IBS--A Case Study. Kirsten, Wilma // Positive Health;Apr2012, Issue 193, p1 

    The article describes the case of Sylvia who sought help after being diagnosed with high cholesterol. She was concerned with her future health coming from a family history of cardiovascular disease and cancer. She presented a case of irritable bowel syndrome (IBS) after she suffered stomach...

  • Frequency of Common Variants in Genes Involved in Lipid-Lowering Response to Statins in Chilean Subjects with Hypercholesterolemia. Rosales, Alexy; Pacheco, Alejandro; Cuevas, Alejandro; Saavedra, Nicolás; Zambrano, Tomás; Lanas, Fernando; Salazar, Luis A. // International Journal of Morphology;2011, Vol. 29 Issue 4, p1296 

    lnterindividual differences in activity and expression of the metabolizing enzymes cytochrome P450 (CYP) 3A4 and 3A5 and the multidrug efflux pump P-glycoprotein (P-gp, encoded by ABCB1 gene) contribute considerably to lipid-lowering efficacy of statin treatment in subjects with...

  • Use of Targeted Exome Sequencing in Genetic Diagnosis of Chinese Familial Hypercholesterolemia. Wu, Wen-Feng; Sun, Li-Yuan; Pan, Xiao-Dong; Yang, Shi-Wei; Wang, Lv-Ya // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Familial hypercholesterolemia is an autosomal dominant inherited disease characterized by elevated plasma low-density lipoprotein cholesterol (LDL-C). It is mainly caused by mutations of the low-density lipoprotein receptor (LDLR) gene. Currently, the methods of whole genome sequencing or whole...

  • Familial Hypercholesterolemia: Developments in Diagnosis and Treatment. Klose, Gerald; Laufs, Ulrich; März, Winfried; Windler, Eberhard // Deutsches Aerzteblatt International;8/4/2014, Vol. 111 Issue 31/32, p523 

    Background: Familial hypercholesterolemia (FH) is a congenital disorder of lipid metabolism characterized by a marked elevation of the plasma concentration of LDL (low-density lipoprotein) cholesterol beginning in childhood and by the early onset of coronary heart disease. It is among the...

  • Familial hypercholesterolemia: clues to catching it early. Safeer, Richard // Journal of Family Practice;Aug2015, Vol. 64 Issue 8, p464 

    Here's how to spot the red flags that could signal your patient is at risk and steps you can take to potentially extend his or her life.

  • Comparison of `statin' drugs for hypercholesterolemia. Sadovsky, Richard // American Family Physician;7/1/1998, Vol. 58 Issue 1, p228 

    Presents summary of the article `Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients with Hypercholestermia (the CURVES study),' by P. Jones and others published in the March 1, 1998 issue of the `American Journal for...

  • Effective treatment of hypercholesterolemia. Sadovsky, Richard // American Family Physician;2/15/1997, Vol. 55 Issue 3, p951 

    Focuses on a study by A.O. Marcus, published in a 1996 edition of the `American Journal of Cardiology,' which reviews the prevalence of hypercholesterolemia in the United States population and discusses strategies used by the National Cholesterol Education Program (NCEP) to develop...

  • Fluvastatin: Synthetic cholesterol-lowering agent is safe and effective.  // Modern Medicine;Mar95, Vol. 63 Issue 3, p53 

    Presents an abstract of the article `Efficacy and Safety of Once-daily vs Twice-daily Dosing With Fluvastatin, A Synthetic Reductase Inhibitor, in Primary Hypercholesterolemia,' by W. Insull Jr., D. Black, et al dated November 14, 1994.

  • Psyllium helps patients tolerate GI effects of cholestyramine.  // Modern Medicine;Mar95, Vol. 63 Issue 3, p55 

    Presents an abstract of the article `Psyllium for the Reduction of Cholestyramine-associated Gastrointestinal Symptoms in the Treatment of Primary Hypercholesterolemia,' by J.J. Maciejko, R. Brazg, et al dated November 1994.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics